Once genistein inhibits the Hedgehog-Gli1 signaling pathway, breast cancer cells undergo cell death by downregulating the proteins SMO and/or Gli1, which eventually impede the cancer stem cell survival pathway, it also limits the proliferation of BCSCs and lowers the endurance of cancer stem cells (CSCs). This evidence concerns the gene GLI1 and cancer.